These results corroborate previous findings reporting a pivotal role of SerpinB3 in the activation of the fibrogenic and inflammatory responses in NASH experimental models [12,13]. This evidence concerns the gene SERPINB3 and metabolic dysfunction-associated steatohepatitis.